36
Systems Biology in Bioscience and Medicine DGKL/ÖGLMK  Jena, Oct. 7, 2005 David Wishart, University of Alberta [email protected]

JenaSysBio.ppt

Embed Size (px)

Citation preview

Page 1: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 1/36

Systems Biology in

Bioscience and Medicine 

DGKL/ÖGLMK – Jena, Oct. 7, 2005David Wishart, University of Alberta

[email protected]

Page 2: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 2/36

Genomics, Proteomics &

Systems Biology

1990 1995 2000 2005 2010 2015 2020

Genomics 

Proteomics 

Systems Biology 

Page 3: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 3/36

What is Systems Biology?

• Systems Biology - Systems biologyis the study of an organism, viewed asan integrated  and in teract ing network  of genes, proteins and biochemicalreactions. The integration of genomics,proteomics, metabolomics & modeling

• The Goal: Predic t ive, Preventative andPersonal ized Medicine -- Leroy Hood  

Page 4: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 4/36

What’s it good for? 

• Basic Science/”Understanding Life” 

• Predicting Phenotype from Genotype

Understanding/Predicting Metabolism• Understanding Cellular Networks

• Predicting Disease Outcome/Prognosis

• Understanding Pathogenicity/Toxicity• Predicting Adverse Drug Reactions

• Improving Medical Efficiency/Efficacy

Page 5: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 5/36

Systems Biology isMultidisciplinary

Page 6: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 6/36

Page 7: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 7/36

Different Ways of Viewing

the World• Physicists

• Chemists

• Biologists

Page 8: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 8/36

A Fundamental Difference

• What happens if I drop this ball? – Phys ics -- predict ive

What happens if I mix this acid withthat base? – Chem istry -- predict ive

• What happens if this TGF receptor isphosphorylated? – Bio logy -- observational

Page 9: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 9/36

THE Grand Challenge… 

Making B ioscience & Medic ine Predict ive Sciences

Page 10: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 10/36

How To Do

This?

Page 11: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 11/36

Going From “Omics” to

“Metrics” • Genomics Genometrics

• Proteomics Proteometrics

• Metabolomics Metabometrics

• Phenomics Phenometrics

• Bioinformatics Biosimulation

• Quanti fy, quan t i fy, quan t i fy  

Page 12: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 12/36

Going From Networks in v ivo  to Networks in si l ico

Page 13: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 13/36

Going From Model Systemsto Medicine

Page 14: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 14/36

Systems Biology in Medicine•

Still in its infancy… • Ethnopharmacology & traditional meds

• Integrated biodiagnostics (combined

microarray, ICAT-MS and metabolite“profiles” – multicomponent biomarkers)

• Adverse drug response prediction and

monitoring (personalized medicine)• Understanding complex metabolic

diseases (cachexia, obesity, diabetes)

Clinical Lab Medicine Leads the Way

Page 15: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 15/36

The Pyramid of Life

25,000 Genes 

2500 Enzymes 

1400Chemicals 

Metabolomics

Proteomics

Genomics 

Page 16: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 16/36

Why Are MetabolitesRelevant?

Metabolites are the Canaries of the Genome

Page 17: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 17/36

Human Metabolome Project

• $7.5 million Genome Canada Projectlaunched in Jan. 2005

• Mandate to quantify (normal andabnormal ranges) and identify allmetabolites in urine, CSF, plasma andWBC’s 

• Make all data freely and electronicallyaccessible (HMDB)

• Make all cmpds publicly available (HML)

Page 18: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 18/36

Traditional Metabolite

Analysis

HPLC, GC, CE, MS 

Page 19: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 19/36

New MetabolomicsApproaches

Page 20: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 20/36

The HMDB & the HML

• HMDB is the publicface of the HMP

• Freely web-

accessible databaseproviding detailedinformation onmetabolites,

chemistry, enzymes,diseases, pathways

• Links metabolometo genome

• HML is the HumanMetabolome Library

• Repository of

chemical samplesfor publicredistribution

• Includes purchased,

isolated &synthesized cmpds(many unique orrare cmpds)

Page 21: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 21/36

Page 22: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 22/36

Page 23: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 23/36

Metabolic Modeling 

Atomic Scale0.1 - 1.0 nmCoordinate dataDynamic data0.1 - 10 nsMolecular dynamics

Meso Scale1.0 - 10 nmInteraction dataKon, Koff, Kd10 ns - 10 msMesodynamics

Continuum Model10 - 100 nmConcentrationsDiffusion rates10 ms - 1000 sFluid dynamics

Page 24: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 24/36

SimCell

http:/ /wishart.biology.ualberta.ca/SimCell/

Page 25: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 25/36

Acetyl-CoA

Citrate

Isocitrate

-Ketoglutarate

Succinyl-CoASuccinate

Fumarate

L-Malate

Oxaloacetate

Glycerol Pyruvate

Acetate

1

2

Succinate dehydrogenase

Fumarate Reductase

The TCA Cycle & SimCell

Page 26: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 26/36

Succinate Production

Observed Predicted (SimCell)

Page 27: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 27/36

The Human Metabolome

Library

10 mg – 10 g of ~1400 human metabolites

Page 28: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 28/36

The HML Allows One To… 

• Access rare or unusual metabolites asreferences or standards for MS, HPLC,GC-MS or NMR analyses

• Compare newly isolated compoundswith known cmpds (saves onreinventing the wheel)

• Use these compounds as precursors tosynthesize new metabolites

• Screen for potential transcr. modulators

Page 29: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 29/36

Metabolic Profiling: ThePossibilities

• Genetic Disease Tests

• Nutritional Analysis

• Clinical Blood Analysis

• Clinical Urinalysis

• Cholesterol Testing

• Drug Compliance

• Dialysis Monitoring

• MRS and fMRI

• Toxicology Testing

• Clinical Trial Testing

• Fermentation Monitoring

• Food & Beverage Tests

• Nutraceutical Analysis

• Drug Phenotyping

• Water Quality Testing

• Petrochemical Analysis

Page 30: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 30/36

-25 

-20 

-15 

-10 

-5 

10 

15 

20 

25 

-30  -20  -10  0  10 

PC1 

PC2 

PAP

ANIT

Control

ANIT

PAP

Control

Principal Component Analysis 

NMR Metabolic Profiling and

Drug Toxicology

Page 31: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 31/36

Genetic DiseaseTesting via NMR

Page 32: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 32/36

140+ Detectable Conditions Adenine

PhosphoribosyltransferaseDeficency

Adenylosuccinase Deficiency

Alcaptonuria

 -Aminoadipic Aciduria

b-Aminoisobutyric Aciduria

 -Aminoketoadipic Aciduria

Anorexia Nervosa

Argininemia

Argininosuccinic Aciduria

Aspartylglycosaminuria

Asphyxia

Biopterin Disorders

Biotin-responsive MultipleCarboxylase Deficiency

Canavan’s Disease 

Carcinoid Syndrome

Carnosinemia

CerebrotendinousXanthomatosis/sterol 27-hydroxylaseDeficiency

Citrullinemia

Cystathioninemia

Cystinosis

Cystinuria (Hypercystinuria)

Diabetes

Dibasic Aminoaciduria

Dicarboxylic Aminoaciduria

Dichloromethane Ingestion

Dihydrolipoyl DehydrogenaseDeficiency

DihydropyrimidineDehydrogenase Deficiency

DimethylglycineDehydrogenase Deficiency

Essential Fructosuria

Ethanolaminosis

Ethylmalonic Aciduria Familial Iminoglycinuria

Fanconi’s Syndrome 

Folate Disorder

Fructose Intolerance

Fulminant Hepatitis

Fumarase Deficiency

Galactosemia

Glucoglycinuria

Glutaric Aciduria Types 1 & 2

Glutathionuria

Glyceroluria (GKD)

D-Glyceric Aciduria

Guanidinoacetate-Methyltransferase Deficiency

Hartnup Disorder

Hawkinsinuria

Histidinemia

Histidinuria

Homocystinsufonuria

Homocystinuria

4-Hydroxybutyric Aciduria

2-Hydroxyglutaric Aciduria

Hydroxykynureninuria

Hydroxylysinemia

Hydroxylysinuria

3-Hydroxy-3-methylglutaric Aciduria 3-Hydroxy-3-methylglutaryl-Co A

Lyase Deficiency

Hydroxyprolinemia

Hyperalaninemia

Hyperargininemia (Argininemia)

Hyperglycinuria

Hyperleucine-Isoleucinemia

Hyperlysinemia

Hyperornithinemia Hyperornithinemia-

Hyperammonemia-HomocitrullinuriaSyndrome (HHH)

Hyperoxaluria Types I & 2 

Hyperphenylalaninemia

Hyperprolinemia

Hyperthreoninemia

Page 33: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 33/36

Applications in Clinical Analysis• 14 propionic acidemia

• 11 methylmalonic aciduria

• 11 cystinuria

• 6 alkaptonuria

• 4 glutaric aciduria I

3 pyruvate decarboxylase deficiency• 3 ketosis

• 3 Hartnup disorder

• 3 cystinosis

• 3 neuroblastoma

• 3 phenylketonuria

• 3 ethanol toxicity

• 3 glycerol kinase deficiency

• 3 HMG CoA lyase deficiency

• 2 carbamoyl PO4 synthetase deficiency

• 96% sensitivity and 100%specificity in ID of

abnormal from normal by

metabolite concentrations

• 95.5% sensitivity and

92.4% specificity in ID of

disease or condition by

characteristic metaboliteconcentrations

• 120 sec per sample  Clinical Chemistry 47, 1918-1921 (2001). 

Page 34: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 34/36

Page 35: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 35/36

Summary

• Systems Biology requires the integrationof data archiving, experimentation andnovel computational approaches

• Some of the first applications of systemsbiology to medicine will involve linkingmetabolomics with clinical chemistry

• New modeling approaches are emergingthat are making bioscience and medicine“predictive” 

Page 36: JenaSysBio.ppt

8/13/2019 JenaSysBio.ppt

http://slidepdf.com/reader/full/jenasysbioppt 36/36

Danke...